Inventor · disambiguated record
Sunil Kumar Kc
Also filed as: KUMAR KC SUNIL
27 granted patents·2 pending applications·1,547 citations·filing 2013–2024
98Inventor score
Top patents by PatentIndex Score
29 records- 0199US9828372B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 28, 2017·49 cites·36 claims
- 0299US9586977B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Mar 7, 2017·49 cites·22 claims
- 0399US9381192B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jul 5, 2016·49 cites·47 claims
- 0499US9233104B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 12, 2016·67 cites·28 claims
- 0599US9199991B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Dec 1, 2015·70 cites·38 claims
- 0699US8987298B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 24, 2015·77 cites·79 claims
- 0799US8901150B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Dec 2, 2014·77 cites·30 claims
- 0899US8703794B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Apr 22, 2014·81 cites·20 claims
- 0999US8697887B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2013·Granted Apr 15, 2014·104 cites·23 claims
- 1099US8673936B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 18, 2014·85 cites·28 claims
- 1199US8664241B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 4, 2014·83 cites·30 claims
- 1299US8618128B11H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 31, 2013·84 cites·30 claims
- 1399US8604052B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 10, 2013·92 cites·18 claims
- 1498US9802916B2Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2015·Granted Oct 31, 2017·52 cites·3 claims
- 1598US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 1698US9090613B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jul 28, 2015·84 cites·23 claims
- 1798US9067939B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jun 30, 2015·75 cites·18 claims
- 1898US9012472B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Apr 21, 2015·73 cites·77 claims
- 1998US8883822B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Nov 11, 2014·76 cites·16 claims
- 2098US8846714B21H-pyrazolo[3,4-β]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Sep 30, 2014·82 cites·32 claims
- 2195US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
- 2294US9908867B23-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 6, 2018·20 cites·8 claims
- 2394US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
- 2493US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
- 2591US9493437B2β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 2690US9533976B2γ-diketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Jan 3, 2017·9 cites·3 claims
- 2774US2025171466A1Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2865US2019119276A13-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2018·Application pending·0 cites
- 2956US10669240B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Sunil Kumar Kc files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →